Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reveal a careful examination of the OCEAN trial, with posts highlighting that rivaroxaban and aspirin had similar stroke risks after successful ablation, using technical terms and detailed statistics that indicate a high level of engagement and interest. Although some express hopeful significance for specific patient subgroups, overall tone remains analytical, emphasizing data interpretation over overt emotional reactions.
Most discussions accept the study’s findings that rivaroxaban did not significantly outperform aspirin in preventing strokes post-ablation, indicating moderate agreement.
The posts show high curiosity about the trial results, with many referencing specific details like the OCEAN trial and risk percentages, reflecting strong engagement.
Numerous contributions analyze methodology, mention clinical implications, and cite data, demonstrating deep involvement in understanding the research.
While the discussions are detailed, they mainly serve academic and professional audiences, suggesting a moderate influence on wider practice change but notable importance in the scientific community.
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0CMSIaOdW @AHAScience | #AHA25 https://t.co/swfGirToPG
1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rates in DOAC and ASA arm: 2.1% vs 3.5% Sample size: beta 0.2, alpha 0.05, delta RR 0.6 (? too optimistic) Sample size: 1572 https://t.co/A0UFvemybI
In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results: nej.md/3LsRJ86 #AHA25
In the OCEAN trial, patients with successful AFib ablation at least 1 year prior, aspirin was noninferior to DOAC for stroke https://t.co/erBaww8ee1
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation Among patients who had had successful catheter ablation for atrial fibrillation at least 1 year earlier and had risk factors for stroke, treatment with rivaroxaban did not result in a significantly https://t.co/DyvJwuKOB0
This video discusses recent research on left atrial appendage closure as a safe and effective alternative to anticoagulation in high-risk atrial fibrillation patients. It highlights reduced bleeding complications and…
Join our scientific team discussing the most impactful papers of the month, including lipid-lowering therapy in acute coronary syndrome, semaglutide's effect on cardiovascular outcomes, and a new obesity treatment…
【不整脈診療へのインパクト】 NEJMに掲載された最新RCT「Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation」が、AFアブレーション成功後の抗凝固療法継続の是非に一石を投じました。 #AFib #カテーテルアブレーション #抗凝固療法 URL: https://t.co/WJwQJo1oq3
【#AFib 診療へのインパクト】NEJMにOCEAN試験が掲載。アブレーション成功後の抗凝固薬（DOAC）継続の是非に一石を投じるRCT。CHA₂DS₂-VAScスコア高値でも、リバーロキサバンはアスピリンに対し脳卒中予防で有意差なし（P=0.28）。 [https://t.co/WJwQJo1oq3](https://t.co/WJwQJo1oq3)
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation https://t.co/APqQ2owegF
#OCEAN RCT- event rates too low to assess #rivaro vs #ASA, but look at extremely low risk of stroke, systemic embolism, or new covert stroke after #PVI in pts at risk: 0.31/100 pts/y rivaro vs 0.66 ASA!!
RT @igormorr: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine Rivaroxab…
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/Z9SyNlNWY0
RT @drraviele: https://t.co/KFiI2FdPJh
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation #science #publication #research #journal https://t.co/CnDCXbjibm
【RCT】カテーテルアブレーションが成功したCHA2DS2-VAScスコア1点以上（女性やリスク因子として血管疾患のある患者は2点以上）の心房細動患者へのリバーロキサバンは、アスピリンと比較して、脳卒中、全身性塞栓症、隠れ塞栓性脳卒中の複合転帰に関して差がなかった。 #ペ読 https://t.co/pQdKLVXAk4
RT @drdavemd: In the OCEAN trial, patients with successful AFib ablation at least 1 year prior, aspirin was noninferior to DOAC for stroke…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @drdavemd: In the OCEAN trial, patients with successful AFib ablation at least 1 year prior, aspirin was noninferior to DOAC for stroke…
Un an après une ablation sans récidive de la fibrillation atriale, le #rivaroxaban n'apparaît plus nécessaire https://t.co/GGP8uGoEjG https://t.co/MOzHdBo9Fv
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
In the OCEAN trial, patients with successful AFib ablation at least 1 year prior, aspirin was noninferior to DOAC for stroke https://t.co/erBaww8ee1
成功AFアブレーション後≥1年を対象としたRCT（OCEAN）で，リバーロキサバンvsアスピリン．3年後の脳卒中／全身性塞栓症／MRIで診断される潜在性塞栓性梗塞を減らせず（RR 0.56），大出血も増えるとはいえなかった（HR 2.51）．ただし，症例が少なかった． https://t.co/X1Eo5VvEDc
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/psjAbr5NPO
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @rincondesisifo: (NEJM) Tto antitrombótico tras una ablación con catéter satisfactoria en pac con FA https://t.co/OzhAq009dq ECA https:/…
(NEJM) Tto antitrombótico tras una ablación con catéter satisfactoria en pac con FA https://t.co/OzhAq009dq ECA https://t.co/vdyv81ocnq
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @peterkistler3: Congrats @atulverma_md | much needed evidence to inform guidelines for stroke protection after AF ABL. OCEAN + ALONE AF…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @drraviele: https://t.co/KFiI2FdPJh
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. https://t.co/dLQZzMjNlZ
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @kaulcsmc: 1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rat…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rates in DOAC and ASA arm: 2.1% vs 3.5% Sample size: beta 0.2, alpha 0.05, delta RR 0.6 (? too optimistic) Sample size: 1572 https://t.co/A0UFvemybI
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @joselmerino: OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic…
https://t.co/KFiI2FdPJh
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @joselmerino: OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation #science #publication #research #publications https://t.co/F7wpkY62x6
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @atulverma_md: I want to thank all of the patients, investigators, committees, George Wells, the UOHI statisticians, Sonya Jancar, David…
RT @atulverma_md: I want to thank all of the patients, investigators, committees, George Wells, the UOHI statisticians, Sonya Jancar, David…
RT @atulverma_md: I want to thank all of the patients, investigators, committees, George Wells, the UOHI statisticians, Sonya Jancar, David…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/yWuvTleKf3
RT @FormigaFrancesc: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine ht…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @joselmerino: OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic…
RT @joselmerino: OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
抄録
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @atulverma_md: I want to thank all of the patients, investigators, committees, George Wells, the UOHI statisticians, Sonya Jancar, David…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
RT @mirvatalasnag: #AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, s…
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/ZL4Wco2CnA
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @NEJM: Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0…
Original Article: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (OCEAN trial) https://t.co/S0CMSIaOdW @AHAScience | #AHA25 https://t.co/swfGirToPG
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/zSw2C5Rg2f
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/Hbr7KX0q1c @chemachir @IcyfaSemi @SECgeriatrica @markinho_gc @jtorresmacho @SABOURETCardio @JuliaSellerm @joscarlor2 @angperi @Sabater71 @Medtorek
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @drbennisahmed: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation Among patients who had had successful…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @drbennisahmed: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation Among patients who had had successful…
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine https://t.co/3mzaSD449q
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation Among patients who had had successful catheter ablation for atrial fibrillation at least 1 year earlier and had risk factors for stroke, treatment with rivaroxaban did not result in a significantly https://t.co/DyvJwuKOB0
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
RT @DrDamluji: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation | New England Journal of Medicine Rivaroxaban was no better than aspirin in reducing stroke. https://t.co/PHK5qukt0K @mencardio @siac @CardiologiaSVC https://t.co/lMtXaZiJdr
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. https://t.co/dLQZzMjfwr
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation: @NEJM @AHAScience #AHA25
In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results: nej.md/3LsRJ86 #AHA25
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. nejm.org. Antithrombotic Therapy after Successful Catheter Ablation for. 1 wk · Neil Swemmer. I seem to be ...
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2509688.
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
Ny forskning indikerar att patienter med låg strokerisk kan avbryta antikoagulantia efter lyckad ablation, men mer studier behövs framhåller ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post-ablation (blood thinners).
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
DOI: 10.1056/nejmoa2509688. Provided by American Heart Association. Citation: Ablation reduces stroke risk for atrial fibrillation and may ...
... 10.1056/NEJMoa2509688 Copyright © 2025 1- 30- 20- 0- Aspirin 10- 6 12 Rivaroxaban 18 24 30 36 6 12 18 No. at Risk Aspirin Rivaroxaban 24 ...
... fibrillation" N Engl J Med 2025; DOI: 10.1056/NEJMoa2509688. Comment. Please enable JavaScript to view the comments powered by Disqus.
2025;doi:10.1056/NEJMoa2509688. Disclosures: The OCEAN trial was funded by Bayer. Patel reports consulting for Bayer, Esperion and Janssen ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
2d
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
2d
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
Anne Byrne Tumbarello
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
https://www.nejm. org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners) ...
Anne Byrne Tumbarello
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
org/doi/full/10.1056/NEJMoa2509688. New study published in JAMA on anticoagulants post- ablation (blood thinners). Something to discuss with ...
AP
N
SK
DS
AM
循医
し
A
RL
SC
TH
PS
LC
P
OH
AF
MG
TO
JM
MN
南P
AG
H
DZ
JR
R
MZ
NK
JP
NS
RP
GR
ÁG
GC
DM
LP
KF
AC
ĐH
HR
AM
AM
VP
HE
NF
NR
IT
GT
RE
JM
PW
AP
KP
ME
DT
PL
VC
JR
RA
AS
C
AD
CM
MM
LD
PP
AA
B
EP
BF
RM
LM
CD
MU
DB
ER
DA
SM
JM
NM
NR
BI
A
AB
GZ
AA
TU
AR
OM
DD
DC
C
MD
FP
PT
M
TM
RP
LP
DJ
RA
Rع
JE
RE
H
J
K
H
JG
MG
宇T
HH
M
Y循
DF
Mا
YM
TÖ
RM
LG
HM
RP
TS
AR
C
SC
JP
旅T
BM
EJ
AC
JB
VS
FF
AA
SN
PF
DS
D
SA
RJ
ID
FG
IM